You are not logged in.

Complete molecular response (CMR) rate With nilotinib in patients (pts) With chronic myeloid leukemia in chronic phase (CML-CP) without CMR after ≥ 2 Years on imatinib : preliminary results from the randomized ENESTcmr trial of nilotinib 400 mg twice da

Hughes, Timothy P., Lipton, Jeffrey H., Leber, Brian, Spector, Nelson, Cervantes, Francisco, Pasquini, Ricardo, Clementino, Nelma, Schwarer, Anthony P., Mahon, Francois-Xavier, Rea, Delphine, Yeung, David T., Kamel-Reid, Suzanne, Bendit, Israel, Reynolds, John, Williams, Lisa, Szczudlo, Tomasz and Branford, Susan 2011, Complete molecular response (CMR) rate With nilotinib in patients (pts) With chronic myeloid leukemia in chronic phase (CML-CP) without CMR after ≥ 2 Years on imatinib : preliminary results from the randomized ENESTcmr trial of nilotinib 400 mg twice daily (BID) vs imatinib, Blood, vol. 118, no. 21, Abstract # 606, pp. 1-1.

Attached Files
Name Description MIMEType Size Downloads

Title Complete molecular response (CMR) rate With nilotinib in patients (pts) With chronic myeloid leukemia in chronic phase (CML-CP) without CMR after ≥ 2 Years on imatinib : preliminary results from the randomized ENESTcmr trial of nilotinib 400 mg twice daily (BID) vs imatinib
Author(s) Hughes, Timothy P.
Lipton, Jeffrey H.
Leber, Brian
Spector, Nelson
Cervantes, Francisco
Pasquini, Ricardo
Clementino, Nelma
Schwarer, Anthony P.
Mahon, Francois-Xavier
Rea, Delphine
Yeung, David T.
Kamel-Reid, Suzanne
Bendit, Israel
Reynolds, John
Williams, Lisa
Szczudlo, Tomasz
Branford, Susan
Journal name Blood
Volume number 118
Issue number 21
Season Abstract # 606
Start page 1
End page 1
Total pages 1
Publisher American Society of Hematology
Place of publication Washington, D. C.
Publication date 2011-11
ISSN 0006-4971
1528-0020
Keyword(s) complete molecular response (CMR) rate
nilotinib
patients
chronic myeloid leukemia in chronic phase (CML-CP)
imatinib
preliminary results
randomized ENESTcmr trial
Notes Alternative source title : Blood (ASH Annual Meeting Abstracts); Oral presentation at American Society of Hematology. Annual Meeting (53rd : 2011 : San Diego, California) held from 10 - 13 Dec. 2011
Language eng
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C2.1 Other contribution to refereed journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30060164

Document type: Journal Article
Collection: Faculty of Health
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 186 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 30 Jan 2014, 10:34:52 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.